20 March 2017

Win a spot to pitch your highly innovative cancer research related business case to an audience of VC and pharma! Ttopstart BV and Merck Ventures are proud to announce the first Biotechnology Showcase Contest on Cancer & Cancer Immunology.

Highly ambitious cancer and cancer immunology researchers are invited to participate in the Biotechnology Showcase Contest. We are looking for people with an entrepreneurial mindset who wish to further exploit the outcomes of their research. Your cutting-edge science should be supported by (novel) in-house data on crucial elements of the scientific hypothesis, e.g. proof of principle. Ideally, in vitro or in vivo proof of concept would be present but this is not mandatory.

In case your application is selected you gain the opportunity to pitch your research to the audience of biopharmaceutical executives and investors. Together they represent over €1 billion in available funds to invest in promising, innovative concepts. In addition, you will receive a travel expense compensation* and a free service by ttopstart to develop the business case for your project.

Should your pitch proposal be granted one of the 2 available spots, you will join the other invited speakers to give a pitch on your research and commercial plans to the audience. Pitchers are requested to give a presentation of 8 minutes. Following this the audience will be allowed to give feedback and ask questions.
Deadline for submitting your Pitch Proposal: 1 April, 2017, 17:00 CET

Download the Pitch Proposal Template
Draft your Pitch Proposal
Upload your Pitch Proposal in PDF-format in the “Submit your proposal” tab before the deadline

Biotechnology Showcase: 3 May, 2017, 13:00 – 20:00 CET

The Biotechnology Showcase is a partnering conference aimed to provide researchers with innovative breakthrough developments with an opportunity to pitch to, and meet with, investors and pharmaceutical executives. During the course of one day, in the beautiful environment of Amsterdam and the Royal Tropical Institute, ttopstart and Merck Ventures create the perfect environment to foster longstanding relations. This is the only European showcase focusing on very early scientific innovation – both investors and candidates are selected for this specific purpose. 

More information? E-mail louise.hoppel@radboudumc.nl

Related news items


Exploration meeting Academic Alliance on Oncology

2 December 2019 Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology. read more

KWF Roadshow 11 November 2019

10 October 2019 In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field. read more

Internal KWF review procedure 2020

13 June 2019 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more

Internal KWF review procedure 2019

4 April 2019 In agreement with the existing policy the research board and Radboudumc Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more

Internal KWF review procedure 2019

19 December 2018 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more

Internal KWF review procedure December 2018

13 September 2018 First deadline is approaching. 24 October 2018 is the deadline for the registration of new applications. read more